GlaxoSmithKline Close To Poaching Royal Bank of Scotland (RBS)'s Sir Philip Hampton As Next Chairman

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline is hoping to bag Sir Philip Hampton from Royal Bank of Scotland as its new chairman, it has emerged.

Britain’s biggest drug maker could announce the appointment as early as next month, according to Sky.

GSK has been searching for a successor to Sir Christopher Gent, who has chaired its board over the past decade, for several months.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC